Medilevo
(8R,9S,10R,13S,14S,17R)-13-Ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 13109.
Registration
- Applicants
- 1
- Registrations
- 2
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Cipla Medpro (Pty) Ltd | Medilevo | 0,75 mg, 1,5 mg | 360168, 440808 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Medilevo 0,75 MG EACH TABLET CONTAINS LEVONORGESTREL 0,75 mg | 0,75 mg | 36016836/21.8.2/0168 | Registered | Not determined | None |
| Medilevo 1,5 MG EACH TABLET CONTAINS LEVONORGESTREL 1,5 mg | 1,5 mg | 44080844/21.8.2/0808 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Levonorgestrel
- when administered via an Intra Uterine System;
- except when intended for oral contraception; (S3)
- except when intended for emergency post coital contraception. (S2)
Consolidated Schedules 06 July 2026, lines 6911 to 6917
S3: Levonorgestrel
- when intended for oral contraception
- except when intended for emergency post coital contraception; (S2)
- except when administered via an Inta-Uterine System. (S4)
Consolidated Schedules 06 July 2026, lines 3880 to 3886
S2: Levonorgestrel
- when intended for emergency post coital contraception;
- except when intended for oral contraception; (S3)
- except when administered via an Intra Uterine System. (S4)
Consolidated Schedules 06 July 2026, lines 2234 to 2240
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.